Other than the hundreds of millions of new shareholder monies and new borrowings and Enhanze upfronts that we’ve blown on failed cancer, cellulite, insulin etc products. If we’d stuck with Enhanze the share price would be over $100 by now. With all the dilution we’re never going to see that level now.